CMS Takes Aim At PBMs, Not Drug Makers, In Part D Proposed Rule

By John Wilkerson / November 21, 2017 at 1:02 PM
The Part D rule that CMS proposed Thursday (Nov. 16) targets pharmacy benefit managers by proposing to make the middlemen share rebates and other pharmacy fees with beneficiaries, instead of pocketing those savings. Other major changes to the drug benefit program that CMS proposes include making it easier for pharmacies to enter specialty pharmacy networks, lowering beneficiary cost-sharing on biosimilars and letting insurance companies offer similar drug plans in the same market. The proposed rule also includes several Medicare Advantage...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.